Brisbane Times
·general
·2 hours ago
Proteomics diagnostic tests shift from lab coats to commercial launch
Proteomics International Laboratories transitioned from research to commercial launch this week under CEO David Morris. The Perth-based company announced a three-year plan to market its diagnostic tests, starting with its PromarkerD diabetes test, targeting 20,000 tests annually in Australia. The firm aims for significant growth by establishing distribution networks and reimbursement submissions in both Australia.
Summary by Glance · Brisbane Times
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI